Author:
Wu Mingting,Wang Zhenyan,Shi Xiaoqian,Zan Danni,Chen Hong,Yang Shuqiao,Ding Fangping,Yang Liu,Tan Pingping,Ma Runlin Z.,Wang Jing,Ma Lishuang,Ma Yingmin,Jin Jiawei
Abstract
Abstract
Background
Idiopathic pulmonary fibrosis (IPF) bears high mortality due to unclear pathogenesis and limited therapeutic options. Therefore, identifying novel regulators is required to develop alternative therapeutic strategies.
Methods
The lung fibroblasts from IPF patients and Reticulocalbin 3 (RCN3) fibroblast-selective knockdown mouse model were used to determine the importance of Rcn3 in IPF; the epigenetic analysis and protein interaction assays, including BioID, were used for mechanistic studies.
Results
Reticulocalbin 3 (RCN3) upregulation is associated with the fibrotic activation of lung fibroblasts from IPF patients and Rcn3 overexpression blunts the antifibrotic effects of pirfenidone and nintedanib. Moreover, repressing Rcn3 expression in mouse fibroblasts ameliorates bleomycin-induced lung fibrosis and pulmonary dysfunction in vivo. Mechanistically, RCN3 promotes fibroblast activation by maintaining persistent activation of TGFβ1 signalling via the TGFβ1-RCN3-TGFBR1 positive feedback loop, in which RCN3 upregulated by TGFβ1 exposure detains EZH2 (an epigenetic methyltransferase) in the cytoplasm through RCN3-EZH2 interaction, leading to the release of the EZH2-H3K27me3 epigenetic repression of TGFBR1 and the persistent expression of TGFBR1.
Conclusions
These findings introduce a novel regulating mechanism of TGFβ1 signalling in fibroblasts and uncover a critical role of the RCN3-mediated loop in lung fibrosis. RCN3 upregulation may cause resistance to IPF treatment and targeting RCN3 could be a novel approach to ameliorate pulmonary fibrosis.
Graphical Abstract
Funder
Beijing Municipal Institute of Public Medical Research Development and Reform Pilot Project
Beijing Municipal Natural Science Foundation
Beijing Institute of Respiratory Medicine
open research project from State Key Laboratory of Molecular Developmental Biology
Publisher
Springer Science and Business Media LLC